Skip to content

Understanding the vaccination decision of contacts of persons before and after liver transplantation

Understanding the vaccination decision of contacts of persons before and after liver transplantation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00036459
Enrollment
300
Registered
2025-03-24
Start date
2025-08-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza vaccination status of contacts

Interventions

Group 1: Cross-sectional study, August 2025 - expected January 2026: Online-based questionnaire survey of contacts of transplanted patients or patients listed for transplantation. These patients will

Sponsors

Institut für Allgemeinmedizin, Universitätsmedizin Essen, Medizinische Fakultät der Universität Duisburg Essen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Questionnaire survey contacts: All contacts of pre- and post-LTx patients older than 18 years. Contact persons are defined as persons from the patient's own household or other close caregivers (family members, friends) who have regular (>2x/month) close contact with the patient. Short interviews: The head physician of the liver transplantation outpatient clinic. The chairman of the regional association of statutory health insurance physicians.

Exclusion criteria

Exclusion criteria: Insufficient knowledge of German

Design outcomes

Primary

MeasureTime frame
Proportion of nationally surveyed contacts who received influenza vaccine in the 2024/2025 season Primary outcome: Prevalence rate of influenza vaccination in the last previous season (2024/2025) based on information in the questionnaire.

Secondary

MeasureTime frame
1. quantitative distribution of factors identified in the preliminary study (DRKS00030354) as barriers and facilitators to vaccine uptake among contacts surveyed nationwide. Secondary outcome: Reasons for or against vaccination uptake among the contacts surveyed, and conditions and individual needs that may promote low-threshold access to vaccination (questionnaire survey). 2. another secondary outcome: the proportion of (liver) transplant centres that inform contacts about the need for comprehensive vaccination protection and the information strategies they use to do so, and the quantitative proportion of (liver) transplant centres that have authorisation to vaccinate. (Survey instrument: short interview using a semi-structured questionnaire) 3. Further outcome: Identification of the reasons for or against the authorisation of vaccination in specialised outpatient clinics from the point of view of the associations of statutory health insurance physicians. (Data collection instrument: short interview using a semi-structured questionnaire)

Countries

Germany

Contacts

Public ContactDorothea Dehnen

Institut für Allgemeinmedizin, Universitätsmedizin Essen, Medizinische Fakultät der Universität Duisburg-Essen

dorothea.dehnen@uk-essen.de+492017238036

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026